TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$0.80
+0.07 (+9.08%)
As of Mar 25, 10:09 PM ET ·
Financial Highlights (FY 2025)
Revenue
15.18M
Net Income
3.38M
Gross Margin
43.4%
Profit Margin
22.3%
Rev Growth
+21.2%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 43.4% 43.4% 43.4%
Operating Margin 32.4% 35.9% 36.7%
Profit Margin 22.3% 30.8% 28.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 15.18M 15.27M 16.61M
Gross Profit 6.59M 6.63M 7.21M
Operating Income 4.92M 5.47M 6.09M
Net Income 3.38M 4.70M 4.66M
Gross Margin 43.4% 43.4% 43.4%
Operating Margin 32.4% 35.9% 36.7%
Profit Margin 22.3% 30.8% 28.0%
Rev Growth +21.2% -3.4% +2.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.00M 9.67M 9.42M
Total Equity 26.75M 27.14M 24.11M
D/E Ratio 0.41 0.36 0.39
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.75M 6.30M 6.21M
Free Cash Flow 2.69M 4.04M 4.00M